
Justices to think about thorny dispute between producers of medicine and its generic substitute
Hikma Pharmaceuticals USA v Amarin Pharma presents a fancy dispute between Amarin, the producer of Vascepa, a prescription medicine to cut back coronary heart illness, and Hikma, which markets a generic substitute for Vascepa. With quite a lot of simplification, the overall matter is how laborious it ought to be




